These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 37343271)
1. Serum brain-derived neurotrophic factor reflects the lower inflammation, lipid level, and major adverse cardiac and cerebrovascular events risk in maintenance hemodialysis patients. Du H; Dai H Scand J Clin Lab Invest; 2023 Jul; 83(4):264-270. PubMed ID: 37343271 [TBL] [Abstract][Full Text] [Related]
2. The Potency of Serum Omentin-1 Quantification in Predicting Major Adverse Cardiac and Cerebrovascular Events Risk in Patients Receiving Hemodialysis. Wang H; Xu J; Ding G; Zheng S; Han Y; Wu X Tohoku J Exp Med; 2023 Aug; 260(4):283-291. PubMed ID: 37081620 [TBL] [Abstract][Full Text] [Related]
3. Analysis of influencing factors of anxiety and depression in maintenance hemodialysis patients and its correlation with BDNF, NT-3 and 5-HT levels. Peng X; Feng S; Zhang P; Sang S; Zhang Y PeerJ; 2023; 11():e16068. PubMed ID: 37750080 [TBL] [Abstract][Full Text] [Related]
4. Correlation of serum omentin-1 level with clinical features and major adverse cardiac and cerebral events in patients undergoing continuous ambulatory peritoneal dialysis. Yao C; Ou J; Zhou L; Liu J Scand J Clin Lab Invest; 2023 Apr; 83(2):119-124. PubMed ID: 36847753 [TBL] [Abstract][Full Text] [Related]
5. Serum brain-derived neurotrophic factor in coronary heart disease: Correlation with the T helper (Th)1/Th2 ratio, Th17/regulatory T (Treg) ratio, and major adverse cardiovascular events. Huo Y; Feng Q; Fan J; Huang J; Zhu Y; Wu Y; Hou A; Zhu L J Clin Lab Anal; 2023 Jan; 37(1):e24803. PubMed ID: 36510348 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-497/fibroblast growth factor-23 axis, a predictive indictor for decreased major adverse cardiac and cerebral event risk in end-stage renal disease patients who underwent continuous ambulatory peritoneal dialysis. Liu D; Zhou S; Mao H J Clin Lab Anal; 2020 Jun; 34(6):e23220. PubMed ID: 32077150 [TBL] [Abstract][Full Text] [Related]
7. The occurrence and potential predictive factors of major adverse cardiac and cerebral events in end-stage renal disease patients on continuous ambulatory peritoneal dialysis: A prospective cohort study. Yao C; Zhou L; Huang Q Medicine (Baltimore); 2021 Mar; 100(10):e24616. PubMed ID: 33725825 [TBL] [Abstract][Full Text] [Related]
8. The Correlation Between Major Adverse Cardiovascular and Cerebrovascular Events (MACCE) and miR-142-3p in Maintenance Hemodialysis Patients With End-Stage Renal Disease. Jiang J; Zhou M; Zhang Q; Shen H; Jia Y; Chen Y; Xu X; Jiang H Semin Dial; 2024; 37(5):373-379. PubMed ID: 39111739 [TBL] [Abstract][Full Text] [Related]
9. Circulating brain-derived neurotrophic factor dysregulation and its linkage with lipid level, stenosis degree, and inflammatory cytokines in coronary heart disease. Xia F; Zeng Q; Chen J J Clin Lab Anal; 2022 Jul; 36(7):e24546. PubMed ID: 35666604 [TBL] [Abstract][Full Text] [Related]
10. Plasma brain-derived neurotrophic factor in hemodialysis patients. Shin SJ; Yoon HE; Chung S; Kim YG; Kim DJ Int J Med Sci; 2012; 9(9):772-7. PubMed ID: 23136540 [TBL] [Abstract][Full Text] [Related]
11. [The incidence of aspirin resistance and relevant influencing factors in patients on maintenance hemodialysis]. Zhang C; Cui T; Zhao S; Wang S; Zhang X Zhonghua Nei Ke Za Zhi; 2014 Mar; 53(3):178-83. PubMed ID: 24767203 [TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor-23 correlates with advanced disease conditions and predicts high risk of major adverse cardiac and cerebral events in end-stage renal disease patients undergoing continuous ambulatory peritoneal dialysis. Xu L; Hu X; Chen W J Nephrol; 2019 Apr; 32(2):307-314. PubMed ID: 30465136 [TBL] [Abstract][Full Text] [Related]
13. A matched comparison of serum lipids between hemodialysis patients and nondialysis morbid controls. Kalantar-Zadeh K; Kilpatrick RD; Kopple JD; Stringer WW Hemodial Int; 2005 Jul; 9(3):314-24. PubMed ID: 16191083 [TBL] [Abstract][Full Text] [Related]
14. The relationship between bile acids levels and the prognosis of patients with diabetes on maintenance hemodialysis: a retrospective study. Li B; Peng C; Wang Y; Ma R; Feng Y Ren Fail; 2023 Dec; 45(1):2226221. PubMed ID: 37340970 [TBL] [Abstract][Full Text] [Related]
16. [The study of cause of early death and a matched study for the risk factors in patients undergoing maintenance hemodialysis]. Hua J; Liang M; Shen S; Li C; Xu S Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 May; 27(5):354-8. PubMed ID: 26003639 [TBL] [Abstract][Full Text] [Related]
17. Association of circulating MtDNA with CVD in hemodialysis patients and in vitro effect of exogenous MtDNA on cardiac microvascular inflammation. Fan Z; Feng Y; Zang L; Guo Y; Zhong XY BMC Cardiovasc Disord; 2023 Feb; 23(1):74. PubMed ID: 36755219 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of hemodialysis quality of care indicators in very elderly patients with end stage kidney disease. Kim HW; Jhee JH; Joo YS; Yang KH; Jung JJ; Shin JH; Han SH; Yoo TH; Kang SW; Park JT J Nephrol; 2022 Dec; 35(9):2351-2361. PubMed ID: 35666374 [TBL] [Abstract][Full Text] [Related]
19. Residual daily urine volume association with inflammation and nutrition status in maintenance hemodialysis patients. Yang PY; Lin JL; Lin-Tan DT; Hsu CW; Yen TH; Chen KH; Ho TC Ren Fail; 2009; 31(6):423-30. PubMed ID: 19839818 [TBL] [Abstract][Full Text] [Related]
20. Non-high-density lipoprotein cholesterol may predict the cardio-cerebrovascular risk in patients on maintenance hemodialysis. Luo D; Luo Y; Zou Y; Xu Y; Fu B; Yang D; Yang J; Xu C; Ling S; Li S; Qi A Lipids Health Dis; 2021 Nov; 20(1):159. PubMed ID: 34774042 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]